Senior insider sale
VP of US Regulatory & FDA Rel. at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$309.5K
4.12K shares
What this filing means
PROVOST MIRIAM plans to sell 4.12K shares of TRANSMEDICS GROUP, INC. valued at approximately $309.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/13/2023ACC: 0001972362-23-001174
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
4.12K
Shares to sell
$309.5K
Approx. market value
4.12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
12/13/2023
4.12KTotal acquired4.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/13/2023 | STOCK OPTION EXERCISE COMPENSATION | 4.12K | — |
| Total | 4.12K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.12K
Market value
$309.5K
12/13/2023
Total
Units
4.12K
Value
$309.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/13/2023 | 4.12K | $309.5K | NASDAQ | Planned |
| Total | 4.12K | $309.5K | ||